273 related articles for article (PubMed ID: 23812429)
1. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.
Liu L; Dong Z; Liang J; Cao C; Sun J; Ding Y; Wu D
Oncogene; 2014 Feb; 33(7):909-20. PubMed ID: 23812429
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
[TBL] [Abstract][Full Text] [Related]
3. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
[TBL] [Abstract][Full Text] [Related]
4. POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Zhong Y; Huang H; Chen M; Huang J; Wu Q; Yan GR; Chen D
Oncotarget; 2017 Jul; 8(27):44082-44095. PubMed ID: 28489585
[TBL] [Abstract][Full Text] [Related]
5. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
6. SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling.
Chen J; Chan AW; To KF; Chen W; Zhang Z; Ren J; Song C; Cheung YS; Lai PB; Cheng SH; Ng MH; Huang A; Ko BC
Hepatology; 2013 Jun; 57(6):2287-98. PubMed ID: 23348706
[TBL] [Abstract][Full Text] [Related]
7. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
9. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
12. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
[TBL] [Abstract][Full Text] [Related]
14. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
[TBL] [Abstract][Full Text] [Related]
15. GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway.
Luo C; Xiong H; Chen L; Liu X; Zou S; Guan J; Wang K
Exp Cell Res; 2018 Apr; 365(1):1-11. PubMed ID: 29458176
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
17. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
[TBL] [Abstract][Full Text] [Related]
18. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.
Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y
BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709
[TBL] [Abstract][Full Text] [Related]
19. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
20. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]